Tag: CBT > MedMen Cannabis Company

Virginia

AYR Wellness Awarded Virginia’s HSA I Vertical Cannabis License

The publicly traded multistate cannabis operator will have exclusive medical cannabis licensing rights to the state’s Health Service Area in Northern Virginia.

September 5, 2024

California

MedMen CFO, Directors Resign as Company Enters Bankruptcy Proceedings; Delisting Expected

The cannabis company, which has subsidiaries across the U.S., announced its assignment into bankruptcy pursuant to Canada’s Bankruptcy and Insolvency Act.

April 29, 2024

Executive Leadership Team

MedMen CEO, Executive Chairman Both Step Down; Restructuring Officer Named

Former CEO Ellen Deutsch Harrison also resigned her position from the company’s board.

January 24, 2024

Executive Leadership Team

MedMen Appoints New CEO, Chief Financial Officer

Ellen Deutsch takes the reins as the multistate cannabis operator’s fifth chief executive officer since 2020.

July 6, 2023

Illinois

MedMen Continues Restructuring Efforts Amidst 34% Payroll Reduction

The multistate cannabis operator announced the strategic review of its assets in Arizona, Illinois and Nevada as next steps of those efforts.

February 20, 2023

Finance

Verano Bets $5 Million to Enter Virginia Medical Market

The multistate cannabis operator entered into an agreement to acquire MedMen’s PhamaCann Virginia LLC, which has a license tied up in litigation.

October 13, 2022

Mergers and Acquisitions

Ascend Wellness Calls Off MedMen NY Acquisition After 17 Months

Despite settling an M&A lawsuit in May, Ascend CEO cancels $88-million deal, calling New York a “highly uncertain” regulatory environment.

August 16, 2022

Finance

Ascend Wellness, MedMen Resolve M&A Lawsuit With $88-Million Deal

The settlement includes a $15-million increase in a transaction consideration than began with a $73-million definitive agreement in February 2021.

May 11, 2022

Finance

MedMen Announces Plans to Sell Florida Assets

Florida-based Green Sentry Holdings will purchase MedMen’s operations for $83 million.

March 1, 2022

Finance

MedMen Announces Michael Serruya as Chairman and Interim CEO

Serruya succeeds outgoing Chairman and CEO Tom Lynch, who held the position since 2020 and oversaw the company's operational turnaround.

November 22, 2021

Mergers and Acquisitions

Tilray Acquires Majority Position in Amended MedMen Convertible Notes

The investment provides Tilray a potential accelerated path into the U.S. cannabis market upon federal legalization.

August 18, 2021

Massachusetts

Need to Know: Mass CultivatED Educates, Trains Bay Staters Impacted by Prohibition

The public-private partnership will offer cannabis classes, internships and other programming to people who have been negatively affected by the War on Drugs or live in disproportionately impacted areas.

August 28, 2020